ClearOne is trading at $3.85, down 6.30%, with no October 8 company-specific announcement identified to explain the decline.

  • ClearOne’s investor-relations releases show no release newer than the previously announced merger.
  • The Nasdaq Composite is down 0.60%; broader market pressure may contribute, but does not establish a direct cause.
  • The Cortigent transaction is prior context: reports describe an existing agreement and planned financing, not a confirmed new catalyst today.